Welling Mick M, Duszenko Nikolas, van Meerbeek Maarten P, Molenaar Tom J M, Buckle Tessa, van Leeuwen Fijs W B, Rietbergen Daphne D D
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Departments of Parasitology and Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
J Clin Med. 2023 Jan 24;12(3):918. doi: 10.3390/jcm12030918.
The targeted delivery of anti-cancer drugs and isotopes is one of the most pursued goals in anti-cancer therapy. One of the prime examples of such an application is the intra-arterial injection of microspheres containing cytostatic drugs or radioisotopes during hepatic embolization procedures. Therapy based on the application of microspheres revolves around vascular occlusion, complemented with local therapy in the form of trans-arterial chemoembolization (TACE) or radioembolization (TARE). The broadest implementation of these embolization strategies currently lies within the treatment of untreatable hepatocellular cancer (HCC) and metastatic colorectal cancer. This review aims to describe the state-of-the-art TACE and TARE technologies investigated in the clinical setting for HCC and addresses current trials and new developments. In addition, chemical properties and advancements in microsphere carrier systems are evaluated, and possible improvements in embolization therapy based on the modification of and functionalization with therapeutical loads are explored.
抗癌药物和同位素的靶向递送是抗癌治疗中最受关注的目标之一。这种应用的一个主要例子是在肝栓塞手术期间动脉内注射含有细胞抑制药物或放射性同位素的微球。基于微球应用的治疗围绕血管闭塞展开,并辅以经动脉化疗栓塞(TACE)或放射性栓塞(TARE)形式的局部治疗。这些栓塞策略目前最广泛的应用在于治疗无法治疗的肝细胞癌(HCC)和转移性结直肠癌。本综述旨在描述在临床环境中针对HCC研究的最新TACE和TARE技术,并讨论当前的试验和新进展。此外,评估了微球载体系统的化学性质和进展,并探讨了基于治疗负载的修饰和功能化对栓塞治疗可能的改进。